Evidence Hub

Omega-3 fatty acid supplementation in diabetic nephropathy - systematic review

Adail Orrith Liborio Neto, Artur Ferrer Sandres Melo, Daniel J. Pereira, Vitor Ferrer Sandres Melo, Kátia Calvi Lenzi-Almeida

Editora Científica Digital eBooks, 2021

Abstract

Diabetic nephropathy is a major microvascular complication in patients with diabetes mellitus and the major global cause of end-stage chronic kidney disease. Several studies have recently presented the beneficial effects of n-3 fatty acid supplementation in patients with diabetic nephropathy, many of which focus on their metabolic profiles. Therefore, this study aims to increase the understanding of the relationship between diabetic nephropathy and n-3 fatty acid supplementation, contributing to the growing demand for complementary strategies in the management of this disease. To achieve this goal, a systematic review was conducted that selected the main characteristics of the essays that relate these approaches. The consumption of n-3 fatty acid, regardless of its origin is from plant, animal or formula origin, is directly related to the improvement of renal function in rodents and also in human subjects with diabetic nephropathy; it also plays an important role in preventing the installation of this condition.

How strong is the evidence?

Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free